Business Context and Reporting Period
Company: Ocular Therapeutix, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 7, 2020
Reporting Period: Second quarter ended June 30, 2020
Context: This filing serves to announce the company's financial results for the quarter ended June 30, 2020, incorporating the full press release as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data. It references a press release (Exhibit 99.1) for the actual figures. Consequently, the following metrics are not available in the source text:
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Material Changes
The filing text does not provide specific data to compare against prior periods. It only indicates that financial results for the quarter ended June 30, 2020, were announced on August 7, 2020.
Guidance, Outlook, and Risks
Management Commentary: The text states that the full text of the press release containing management commentary, outlook, and risks is furnished as Exhibit 99.1 and incorporated by reference.
Legal Disclaimer: The information in this Current Report is furnished to comply with Item 2.02 and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor subject to the liabilities of that section, except as expressly set forth by specific reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 7, 2020) for actual revenue, net loss, and cash position figures.
- Verify the specific details of the "Results of Operations" referenced in Item 2.02, as they are not detailed in the cover sheet.
- Confirm the company's status as an emerging growth company (indicated by a check mark in the filing) and any associated election regarding extended transition periods for accounting standards.
- Check the Nasdaq Global Market listing status for the Common Stock (Symbol: OCUL).